Respiratory Drug Delivery
Optimized Inhalation and Nasal Formulations for Effective Pulmonary Absorption
At MedPharm, we specialize in respiratory drug delivery, developing advanced inhalable and nasal formulations designed for precise, efficient, and patient-friendly administration. Our expertise includes liquid sprays, dry powder inhalers (DPIs), and nebulized formulations. We ensure that respiratory drugs achieve optimal lung deposition, rapid onset, and enhanced bioavailability while maintaining regulatory compliance and stability.
Our scientifically driven approach, combined with in-vitro bioequivalence testing, particle size optimization, and GMP-compliant manufacturing, enables the development of high-performance respiratory therapies for conditions such as asthma, COPD, allergic rhinitis, and nasal infections.
Our Expertise in Respiratory Drug Delivery
Nasal Drug Delivery – Targeted and Systemic Absorption
- Nasal sprays, powders, and gels for rapid drug absorption
- Optimized droplet size and viscosity for enhanced retention
- Targeted formulations for conditions like allergies, migraines, and hormone therapies
- Mucoadhesive formulations to improve bioavailability and therapeutic efficacy
Pulmonary Drug Delivery – Optimized Inhalation Therapy
- Nebulized formulations for direct lung delivery and systemic absorption
- Dry Powder Inhalers (DPIs) for controlled pulmonary administration
- Pressurized metered-dose inhalers (pMDIs) for efficient and repeatable dosing
- Particle engineering to optimize aerosolization and deposition in lung tissue
Advanced Formulation and Drug Delivery Technologies
- Optimized excipient selection for enhanced lung and nasal absorption
- Particle size control and spray optimization for improved efficacy
- Bioavailability enhancement strategies for poorly soluble active pharmaceutical ingredients (APIs)
- Seamless integration with in vitro release testing (IVRT) and in vitro permeation testing (IVPT) for regulatory approval
GMP-Compliant Manufacturing and Regulatory Support
- End-to-end respiratory formulation support from early development to commercialization
- Batch-to-batch consistency with stringent quality control measures
- ICH-compliant stability and release testing for inhalation and nasal products
- Regulatory support for IND, NDA, ANDA, and global market approvals
Advantages of MedPharm’s Respiratory Drug Delivery Solutions
- Targeted drug delivery with optimized lung and nasal absorption
- Customizable formulation approaches for controlled-release and sustained effects
- Regulatory-compliant in vitro testing to support IND, NDA, and ANDA submissions
- GMP-compliant manufacturing for clinical and commercial supply
- Seamless integration from early-stage development to full-scale production
Why Choose MedPharm for Respiratory Drug Delivery?
- Industry-leading expertise in inhalable and nasal drug formulations
- Optimized drug delivery strategies for pulmonary and systemic absorption
- Regulatory-compliant analytical testing and stability studies
- Seamless scale-up for clinical and commercial manufacturing
- Advanced technologies for improved deposition and retention
Develop Market-Ready Respiratory Drug Products with MedPharm
With specialized expertise in inhalable and nasal drug delivery, MedPharm ensures that your respiratory formulations are developed with precision, efficacy, and regulatory compliance, helping you achieve clinical and commercial success.
